Thermosome appoints Dr. Ulrich Grau, Dr. Jochen Knolle and Dr. Franz-Robert Klingan to its advisory board

Thermosome GmbH, an emerging biopharmaceutical company, today announces the appointment of Dr. Ulrich Grau, Dr. Jochen Knolle and Dr. Franz-Robert Klingan to its advisory board. Dr. Ulrich Grau has more than 35 years experience in the biopharmaceutical industry spanning from basic R&D functions to executive positions in Pharma and Biotech companies in Germany and the US. Starting his career as a scientist at Hoechst and being one of the key inventors that led to the blockbuster insulin Lantus®, he spent almost two decades at Hoechst/Aventis in different functions, including SVP of late-stage global development.

Read more

  • On 6. Oktober 2016